Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke

Current Drug Targets: CNS and Neurological Disorders

Volumn 4, Issue 2, 2005, Pages 119-120

  Lutsep, Helmi L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acute stroke treatment; Infarct; Ischemia; Neuroprotectant; Neuroprotection; Repinotan

Indexed keywords

REPINOTAN; SEROTONIN 1A AGONIST; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMINAL PAIN; AGITATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; NAUSEA; NERVOUSNESS; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; VOMITING;

ACUTE DISEASE; AGED; BENZOPYRANS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEUROPROTECTIVE AGENTS; SEROTONIN AGONISTS; THIAZOLES; TREATMENT OUTCOME;

EID: 18044387563     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007053544165     Document Type: Review

References (11)

1. Albers, G.W.; Atkinson, R.P.; Kelley, R.E.; Rosenbaum, D.M.; on behalf of the Dextrorphan Study Group. Stroke, 1995, 26 , 254.
2. Davis, S.M.; Albers, G.W.; Diener, H.C.; Lees, K.R.; Norris, J. Lancet, 1997, 349, 32.
3. Mauler, F.; Fahrig, T.; Horvath, E.; Jork, R. Brain Research, 2001, 888, 150.
4. De Vry, J.; Schohe-Loop, R.; Heine, H.G.; Greuel, J.M.; Mauler, F.; Schmidt, B.; Sommermeyer, H.; Glaser, T. J. Pharmacol. Exp. Ther., 1998, 284, 1082.
5. Lutsep, H.L. Current Opinion in Investigational Drugs., 2002, 3, 924.
6. De Vry, J.; Keitrich, H.; Glaser, T.; Heine, H.G.; Horath, E.; Jork, R.; Maertins, T.; Mauler, F.; Opitz, W.; Scherling, D.; Schohe-Loop, R.; Schwarz, T. Drugs Fut., 1997, 22, 341.
7. Alessandri, B.; Tsuchida, E.; Bullock, R.M. Brain Res., 1999, 845, 232.
8. Kline, A.E.; Yu, J.; Horvath, E.; Marion, D.W.; Dixon, C.E. Neuroscience, 2001, 106, 547.
9. Fleckenstein, L.; Roche, L.; Sundaresan, P.R.; Hogan, C.; Heller, A.H.; Knapp, H.R. Annu. Meet. Am. Soc. Clin. Pharmacol., 1998, 99, 11.
10. Bayer HealthCare Satellite Symposium to the 5th World Stroke Congress, Vancouver, BC, June 24, 2004.
11. Teal, P.; Rombout, F.; Rodriquez, M.L.; Cyrus P.; Weber, H. Repinotan (BAY X3702) in acute ischemic stroke: a Randomized Exposure Controlled Trial (RECT). Presented at the 26th International Stroke Conference, San Antonio, Texas, February 2001.